For many adults with diabetes, typical blood sugar targets are 80–130 mg/dL before meals and under 180 mg/dL two hours after starting a meal. A common A1C goal is below 7%, but targets vary by age, pregnancy, medicines, and health risks. Ask your care team what range is safest for you 1.
Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.
See if you qualify →What is a normal blood sugar level if you have diabetes?
Diabetes blood sugar targets are usually target ranges, not one perfect number. For many adults, common goals are 80–130 mg/dL before meals and less than 180 mg/dL two hours after a meal starts, but your own range may differ 1.
Quick facts: common diabetes blood sugar targets
| Check | Common target for many adults with diabetes | What it means |
|---|---|---|
| Before a meal, often called fasting or pre-meal glucose | 80–130 mg/dL | A snapshot before food raises blood sugar 1 |
| Two hours after the start of a meal | Less than 180 mg/dL | Shows how your body handles food and medication timing 1 |
| A1C, also called hemoglobin A1C | Often below 7% | An estimate of average blood glucose over about 3 months 2 |
| Low blood sugar warning level | Often below 70 mg/dL | May need fast action, especially if you use insulin or sulfonylureas 1 |
Why diabetes targets are not the same as “normal” numbers in people without diabetes
In diabetes mellitus, the body does not make enough insulin, does not use insulin well, or both. That can happen in type 1 diabetes, type 2 diabetes, gestational diabetes, and some less common forms; too much glucose can stay in the blood and raise the risk of long-term complications 1.
A target for someone with diabetes is a safe working range. It balances lower average glucose with the risk of hypoglycemia, or low blood sugar, which can be dangerous if it comes on fast 1. For a broader chart across fasting, after meals, and A1C, see our guide to normal blood sugar levels.
How age, pregnancy, other conditions, and medications can change your target
Your clinician may set different goals if you are pregnant, have gestational diabetes, have kidney or heart disease, have frequent lows, live with frailty, or use medicines that can cause hypoglycemia. NIDDK notes that A1C goals can differ when people have other health problems, even though below 7% is common for many adults 2.
What do fasting, after-meal, random glucose, and A1C numbers mean?
Blood glucose changes all day. A fasting plasma glucose, postprandial glucose, random blood glucose, and A1C each answer a different question, so one number rarely tells the whole story 3.
Fasting blood sugar: what it measures
Fasting blood sugar is usually checked after a period without calories, often overnight. It can reflect overnight liver glucose release, insulin resistance, medication effects, and what happened the day before 3.
Two-hour after-meal blood sugar: why timing matters
Two-hour after-meal glucose is usually counted from the start of a meal, not the end. MedlinePlus lists less than 180 mg/dL two hours after the start of a meal as a typical target for many people with diabetes 1.
Random blood sugar: when it can be useful
A random blood sugar is checked at any time. It can help explain symptoms such as shakiness, thirst, frequent urination, blurred vision, or fatigue, but it is harder to interpret without knowing food, exercise, stress, illness, and medication timing 1.
A1C: your approximate 2- to 3-month average
A1C, or hemoglobin A1C, reflects your average blood glucose over roughly the last 3 months. For most people with diabetes, NIDDK lists an A1C goal below 7%, while noting that personal goals can differ 2.
A1C is useful, but it is not perfect. Some blood conditions, pregnancy, recent blood loss, kidney disease, and other factors can make A1C less reliable, so your clinician may compare it with home glucose readings or a continuous glucose monitor report 3.
What blood sugar level is too low?
Hypoglycemia often means blood glucose below 70 mg/dL for people with diabetes. Lows matter because the brain needs glucose, and symptoms can become urgent if blood sugar keeps falling 1.
Why many people use below 70 mg/dL as a low blood sugar warning level
MedlinePlus describes low blood sugar as often below 70 mg/dL. That level is a warning to follow your clinician’s low-glucose plan, especially if you use insulin, sulfonylureas, or other medicines that can lower glucose 1.
Common low blood sugar symptoms
- Shaking, sweating, or feeling anxious 1
- Hunger, dizziness, headache, or weakness 1
- Irritability, confusion, sleepiness, or trouble thinking clearly 1
- Fast heartbeat or feeling like something is wrong 1
Why lows can be urgent, especially with insulin or certain diabetes medicines
Insulin and sulfonylureas can cause blood sugar to fall too low. Severe hypoglycemia can lead to confusion, seizure, loss of consciousness, or injury, so people at risk need a written plan from their diabetes care team 1.
What blood sugar level is too high or alarming?
Hyperglycemia means blood sugar is above your target range. A single high reading may have an explainable cause, but repeated highs, severe symptoms, ketones, vomiting, confusion, dehydration, or trouble breathing can be dangerous and need prompt care 1.
Common high blood sugar symptoms
When repeated high readings should prompt a call to your care team
Call your diabetes care team if your readings are repeatedly above your target, if you are sick and your glucose is harder to manage, or if you do not understand why numbers changed. Your clinician can review meals, activity, infection, stress, medicines, meter technique, and timing before changing a plan 2.
When severe symptoms, ketones, vomiting, confusion, or dehydration need urgent care
Get urgent medical help for confusion, fainting, persistent vomiting, dehydration, trouble breathing, very high readings with ketones, or suspected severe hypoglycemia. Ketones can appear when the body burns fat for energy and may signal a dangerous diabetes emergency, especially in type 1 diabetes 5.
How should you check blood sugar at home?
Home glucose monitoring can use a finger-stick blood glucose meter or a continuous glucose monitor, often called a CGM. The best tool depends on your medicines, risk of lows, cost, comfort, and what your clinician needs to see 3.
Finger-stick glucose meters
A glucose meter uses a small blood drop and a test strip to estimate blood sugar at that moment. Meter readings can be affected by strip storage, hand contamination, device limits, temperature, and user technique, so unexpected readings should be repeated or discussed with a clinician rather than used alone to change medicines 3, 4.
Continuous glucose monitors
A continuous glucose monitor uses a sensor under the skin to estimate glucose often across the day and night. CGM can be especially useful for some people who use insulin, have frequent lows, or need to see patterns after meals, exercise, and sleep 3. You can learn more in our guide to continuous glucose monitoring systems.
Why meter accuracy, test strip handling, and clean hands matter
The FDA accuracy standard for over-the-counter blood glucose meters was updated because small device differences can matter when people make treatment decisions. A review of meter accuracy found that device performance and real-world use conditions both affect readings 4.
How to track readings in a way your clinician can use
- Write down the time, number, and whether it was fasting, before a meal, two hours after a meal, bedtime, or random.
- Note symptoms, exercise, illness, stress, alcohol, and unusual meals.
- Record medication timing, including insulin, metformin, sulfonylureas, SGLT2 inhibitors, GLP-1 medicines, and steroid medicines.
- Bring your meter, CGM report, or app history to visits so your clinician can look for patterns.
What helps blood sugar move toward your target range?
Blood sugar control usually improves through a plan, not one change. Food patterns, activity, sleep, stress, blood pressure, cholesterol, smoking status, weight management when appropriate, and medicines all work together 2.
Food patterns and portion changes
Meal planning can help match carbohydrate intake, protein, fiber, medications, and activity. NIDDK includes healthy eating and weight management, when appropriate, as core parts of diabetes care 2.
Physical activity and resistance training
NIDDK suggests aiming for at least 150 minutes per week of moderate-intensity physical activity, with muscle-strengthening activity two days per week when possible, as part of diabetes management 2. In a 2024 randomized trial in obese men with type 2 diabetes, researchers compared resistance training with aerobic training for FGF-21 and related physiologic measures, supporting that structured exercise has been studied in this group 6.
Sleep, stress, smoking, blood pressure, and cholesterol
Diabetes care is not only about glucose. NIDDK uses the “ABCs” of diabetes care: A1C, blood pressure, cholesterol, and smoking cessation when relevant, because diabetes can affect the heart, kidneys, eyes, nerves, and blood vessels 2.
Diabetes medications and why they should not be changed without a clinician
Diabetes medicines can include insulin, metformin, sulfonylureas, SGLT2 inhibitors, GLP-1 receptor agonists, dual GIP/GLP-1 receptor agonists, and others. Because some can cause lows, dehydration, stomach side effects, or medication interactions, changes should be made with your clinician, not by trial and error 2.
| Your situation | Sensible next step | Why it matters |
|---|---|---|
| You have many fasting readings above your target | Share a log with your diabetes clinician | Fasting highs can reflect overnight glucose release, medication timing, illness, or insulin resistance. |
| Your two-hour after-meal readings are often above target | Review meal pattern, portions, medication timing, and activity | Postprandial glucose shows how your body handles food after eating. |
| You have readings below 70 mg/dL | Follow your low-glucose plan and contact your clinician if lows repeat | Repeated lows can be dangerous, especially with insulin or sulfonylureas. |
| You have overweight, obesity, prediabetes, or type 2 diabetes risk | Ask whether weight-focused care belongs in your plan | Weight management can be one part of blood sugar and cardiometabolic care 2. |
| You are pregnant or may be pregnant | Use pregnancy-specific diabetes care | Gestational diabetes and pregnancy targets are different and need close clinician guidance. |
| You have ketones, vomiting, confusion, dehydration, fainting, or trouble breathing | Seek urgent care now | These can signal a diabetes emergency. |
3-min quiz
Considering weight-focused care as part of your metabolic health plan?
Chia offers online evaluations for eligible adults seeking compounded semaglutide injection or compounded tirzepatide tablets or injections. A licensed US provider reviews your health history and prescribes only when clinically appropriate; a prescription is never guaranteed. Compounded drugs are not FDA-approved.
When weight loss treatment may fit into blood sugar goals at Chia
Weight loss treatment may fit for some adults with overweight, obesity, prediabetes, insulin resistance, or type 2 diabetes risk, but it does not replace diabetes care. Chia’s role is weight-focused telehealth evaluation, not emergency diabetes treatment, insulin replacement, or primary diabetes management.
Who may benefit from a weight-focused evaluation
A weight-focused evaluation may be reasonable if weight, waist size, insulin resistance, prediabetes, or type 2 diabetes risk is part of your health picture. NIDDK includes weight management, healthy eating, activity, and taking medicines as prescribed as parts of diabetes care, but the right plan depends on your diagnosis and safety risks 2. For more context, read our guide to weight loss and diabetes.
Semaglutide at Chia: compounded semaglutide injection through a licensed 503A pharmacy
Semaglutide is a GLP-1 receptor agonist. Brand examples include Ozempic for type 2 diabetes and Wegovy for chronic weight management; Chia offers compounded semaglutide via 503A pharmacy as an injection for eligible patients, with plans currently starting at $249/month 7, 8.
GLP-1 medicines can cause gastrointestinal side effects such as nausea, vomiting, diarrhea, constipation, and abdominal pain, and they are not appropriate for everyone. FDA labels for semaglutide products include warnings and contraindications that clinicians review before prescribing, including personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 7, 8.
Tirzepatide at Chia: compounded tirzepatide tablets or injections, with microdosing plans available
Tirzepatide is a dual GIP/GLP-1 receptor agonist. Brand examples include Mounjaro for type 2 diabetes and Zepbound for chronic weight management; Chia offers compounded tirzepatide via 503A pharmacy as tablets or injections for eligible patients, with microdosing plans available and plans currently starting at $249/month for tablets and $299/month for injections 9, 10.
Tirzepatide products can also cause gastrointestinal side effects and have warnings and contraindications that require clinical review, including the same medullary thyroid carcinoma and MEN2 contraindication listed in FDA labeling 9, 10. Individual results vary, and outcomes for compounded formulations are not evaluated by FDA.
| Chia option | Forms Chia offers | Current starting price | Fit to discuss with a provider |
|---|---|---|---|
| Semaglutide | Injection | From $249/month | Adults seeking a GLP-1 weight-focused evaluation when clinically appropriate |
| Tirzepatide | Tablets or injection; microdosing plans available | Tablets from $249/month; injections from $299/month | Adults who want to discuss a dual GIP/GLP-1 option and form preference |
| Weight + Energy | NAD+ Injection + choice of GLP-1 | From $309/month | Eligible patients who want a weight-focused protocol that includes NAD+ |
| Weight + Muscle | Sermorelin Injection + choice of GLP-1 | From $329/month | Eligible patients who want a weight-focused protocol that includes sermorelin |
Weight + Energy and Weight + Muscle protocols for eligible patients
At Chia, eligible patients may also discuss Weight + Energy, which includes NAD+ injection plus a choice of GLP-1, or Weight + Muscle, which includes sermorelin injection plus a choice of GLP-1. These are weight-focused protocols with provider-guided dosing and follow-up through the patient portal.
How treatment at Chia works
Chia is 100% online: you complete a short health questionnaire, then a licensed US provider reviews it and prescribes only where clinically appropriate. When prescribed, medications are compounded in the US by state-licensed 503A compounding pharmacies and shipped to your door; you can message your care team through the patient portal between visits.
Why Chia does not replace emergency diabetes care or individualized diabetes management
Chia does not manage diabetic ketoacidosis, severe hypoglycemia, insulin emergencies, pregnancy diabetes targets, or urgent medication changes. If your main need is day-to-day insulin adjustment, ketone management, severe symptoms, or complex diabetes care, your diabetes clinician, endocrinologist, or urgent care team is the right place to start.
How can you prepare for a clinician visit about your blood sugar?
A useful diabetes visit starts with patterns, not perfect notes. Bring at least several days of readings if you have them, plus symptoms and medication timing, so your clinician can connect the dots 2.
Readings to bring: fasting, after-meal, bedtime, symptoms, and medication timing
- Fasting readings before breakfast
- Two-hour after-meal readings, counted from the start of the meal
- Bedtime readings if your clinician asked for them
- Any readings below 70 mg/dL or readings with symptoms
- Medication names and timing, including insulin, metformin, sulfonylureas, SGLT2 inhibitors, GLP-1 medicines, and steroids
Questions to ask about your personal A1C and glucose goals
- What fasting range is safest for me?
- What two-hour after-meal range should I aim for?
- What A1C goal fits my age, pregnancy status, medications, and other conditions?
- What should I do if I am sick and my blood sugar is high?
- What is my low blood sugar plan?
When to ask about nutrition support, diabetes education, or an endocrinology referral
Ask about diabetes education or nutrition support if food choices feel confusing, readings swing after meals, or you are starting a new medicine. Ask about endocrinology if you have type 1 diabetes, pregnancy with diabetes, frequent lows, ketones, unclear diagnosis, or hard-to-control blood sugar despite a careful plan 2.
FAQ: diabetes blood sugar numbers
For many adults with diabetes, common targets are 80–130 mg/dL before meals and less than 180 mg/dL two hours after the start of a meal. Your personal target may differ based on age, pregnancy, medicines, low-blood-sugar risk, and other conditions.
A “good” blood sugar count is one that is in your personal target range without causing lows. Many adults use 80–130 mg/dL before meals and under 180 mg/dL after meals as a guide, but your care team may set a different range.
A1C is the lab test often used to estimate average blood sugar over about 3 months. Many adults with diabetes have an A1C goal below 7%, but some people need a different goal for safety.
For many people with diabetes, less than 180 mg/dL two hours after the start of a meal is a common target. One reading above that does not tell the whole story, but repeated readings above your target should be reviewed with your care team.
Blood sugar below 70 mg/dL is often treated as a low blood sugar warning level for people with diabetes. This matters most if you use insulin or medicines such as sulfonylureas that can cause lows.
The number is not the only issue. Get urgent care for severe symptoms such as confusion, fainting, seizure, persistent vomiting, dehydration, trouble breathing, ketones with very high readings, or suspected severe low blood sugar.
Weight management can support blood sugar goals for some people with overweight, obesity, prediabetes, insulin resistance, or type 2 diabetes risk. It should be part of a clinician-guided plan that also considers food, activity, sleep, blood pressure, cholesterol, and medicines. Compounded GLP-1 drugs are not FDA-approved, and outcomes are not established for compounded formulations.
Chia can evaluate eligible adults for weight-focused treatment with compounded semaglutide or compounded tirzepatide when clinically appropriate. Chia does not replace your diabetes clinician, insulin management, pregnancy diabetes care, emergency care, or urgent treatment for severe highs, lows, or ketones.
3-min quiz
Start with a licensed-provider review
If weight is part of your blood sugar or metabolic health plan, Chia can help you explore whether compounded semaglutide, compounded tirzepatide, or a weight-focused protocol is appropriate. The visit is online, a licensed US provider reviews your history, and a prescription is not guaranteed. Compounded medications are not FDA-approved.
References
- 1.MedlinePlus. Blood Glucose: Blood Sugar and Diabetes. U.S. National Library of Medicine, 2026.
- 2.National Institute of Diabetes and Digestive and Kidney Diseases. Managing Diabetes. NIDDK, 2026.
- 3.Mathew TK, Tadi P. Blood Glucose Monitoring. StatPearls. 2024.
- 4.Klonoff DC, Parkes JL, Kovatchev BP, Kerr D, Bevier WC, Brazg RL, et al. Meeting the New FDA Standard for Accuracy of Self-Monitoring Blood Glucose Test Systems Intended for Home Use by Lay Users. Journal of Diabetes Science and Technology. 2018.
- 5.Centers for Disease Control and Prevention. Diabetes Testing. CDC, 2026.
- 6.Duan Y, Lu G. A Randomized Controlled Trial to Determine the Impact of Resistance Training versus Aerobic Training on the Management of FGF-21 and Related Physiological Variables in Obese Men with Type 2 Diabetes Mellitus. Journal of Sports Science & Medicine. 2024.
- 7.Novo Nordisk. Ozempic (semaglutide) injection prescribing information. U.S. Food and Drug Administration. 2025.
- 8.Novo Nordisk. Wegovy (semaglutide) injection prescribing information. U.S. Food and Drug Administration. 2025.
- 9.Eli Lilly and Company. Mounjaro (tirzepatide) injection prescribing information. U.S. Food and Drug Administration. 2025.
- 10.Eli Lilly and Company. Zepbound (tirzepatide) injection prescribing information. U.S. Food and Drug Administration. 2025.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
See if GLP-1 is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.
